FirstEnergy Corp (NYSE:FE) (The Motley Fool) What happened: Shares of First Energy (NYSE:FE) spiked on Monday and were up 15% at 10:45 a.m. EST after......
(read more)January 22 - Market Movers, News - Comments
Array Biopharma Inc (NASDAQ:ARRY): Steve Cohen’s Point72 Asset Management filed an amended 13D. You can check out Point72 Asset Management’......
(read more)September 13 - Hedge Funds - Comments
1. U.S. Stock Market: “U.S. stocks edged lower on Tuesday as weakness in the energy and financial sectors outweighed gains in technology shares.......
(read more)May 30 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
1. U.S. Stock Market: “U.S. stocks wavered on Wednesday as investors digested a batch of weak corporate earnings and President Donald Trump&#......
(read more)May 10 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
1. U.S. Stock Market: “U.S. stocks edged higher on Tuesday, with the Nasdaq briefly touching a record high, on the back of robust earnings, although......
(read more)May 2 - Commodities, Gold, Market Movers, News, Tech - Comments
It’s the beginning of a new week and the three major indexes look once again to open relatively flat. Although the U.K. plans to start the Brexit......
(read more)March 20 - News - Comments
Array Biopharma Inc (NASDAQ:ARRY) and its partner Pierre Fabre took the opportunity at the Society for Melanoma Research Annual Congress to share results......
(read more)November 10 - News, Stock Analysis - Comments
Today is likely to be a very interesting day in the market following the Trump win. Nonetheless, Array Biopharma Inc (NASDAQ:ARRY) is skyrocketing, and......
(read more)November 10 - News, Stock Analysis - Comments
With this month’s two major catalysts now over, the markets are relatively quiet, as all three major indexes are slightly in the green at the start......
(read more)September 28 - Market Movers, News - Comments
The markets are buoyant today after a report showcased a rise in US Consumer Confidence. The consumer confidence index touched its highest level in the......
(read more)September 27 - Market Movers, News - Comments
It’s a red day on Wall Street, as all three major indexes are lower. The Dow is off by over 130 points, the S&P 500 has fallen by 0.6%, and......
(read more)September 26 - Market Movers, News - Comments
The markets are mixed on Wednesday as investors remain cautious amid declining crude prices and rising bond yields, which could pressure stocks. Some......
(read more)September 14 - Market Movers, News - Comments
Array Biopharma Inc (NASDAQ:ARRY) just had its latest NDA accepted by the FDA, and the agency has put forward a PDUFA date for the candidate of June 30......
(read more)September 2 - News, Stock Analysis - Comments
Markets are trading in the green on Friday following easing Brexit fears and optimism over central bank’s intervention. Investors are keenly watching......
(read more)July 1 - Market Movers, News - Comments
Array Biopharma Inc (NASDAQ:ARRY) just reported detailed topline from a recently completed oncology pivotal, and alongside the report, announced it expects......
(read more)June 8 - News, Stock Analysis - Comments
Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience......
(read more)June 3 - Hedge Fund Analysis, Hedge Funds, News - Comments
Most securities that cost less than a dinner at a fast-food restaurant are considered to be too risky, with most intra-day traders or other investors......
(read more)May 31 - Hedge Funds, News - Comments
When it comes to the risk-reward ratio, there are very few sectors which can match up to healthcare. The healthcare universe boasts of several companies......
(read more)March 24 - Hedge Funds, News - Comments
Individual investors might find hedge fund investing quite expensive, considering the 2-and-2o fee structure most hedge funds employ. However, mimicking......
(read more)January 26 - Hedge Funds, News - Comments
The deadline for the current round of 13F filings, for the quarterly period that ended December 31, is February 15. Most market participants find these......
(read more)January 12 - Hedge Funds, News - Comments
It’s Wednesday and the S&P 500 futures are still firmly in the green in pre-market trading despite the fact that the Federal Reserve is set......
(read more)December 16 - Market Movers, News - Comments
Correction: This article has previously mistakenly stated that the Redmile Group had sold shares of Array Biopharma. Therefore, the title and the first......
(read more)September 11 - Hedge Funds, News - Comments
Jeremy Green, the manager of Redmile Group, is still bullish on Array Biopharma Inc (NASDAQ:ARRY) having further increased his holding of the stock......
(read more)August 26 - Hedge Funds, News - Comments
Jeremy Green’s Redmile Group has just acquired more shares of Array BioPharma Inc. (NASDAQ:ARRY). In a Form 4 filed with the U.S. Securities and Exchange......
(read more)August 14 - Hedge Funds, News - Comments
Mark Lampert’s Biotechnology Value Fund recently filed its 13F with the U.S. Securities and Exchange Commission for the reporting period of March 31......
(read more)June 10 - Hedge Fund Analysis, Hedge Funds, News - Comments
Should Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) investors track the following data? At the moment, there are plenty of metrics investors can use to......
(read more)September 17 - News - Comments
Is it smart to be bullish on EXACT Sciences Corporation (NASDAQ:EXAS)? In the financial world, there are a multitude of gauges shareholders can use to......
(read more)September 6 - News - Comments
Is it smart to be bullish on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)? In the eyes of many of your fellow readers, hedge funds are viewed as overrated......
(read more)September 5 - News - Comments
Is Array Biopharma Inc (NASDAQ:ARRY) a good investment? At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most......
(read more)August 30 - News - Comments
Around four in 10 Americans live in places where smog can impact their health. Children and teens are especially vulnerable to higher levels of ozone......
(read more)August 5 - News - Comments
Array Biopharma Inc (NASDAQ:ARRY), a biotech company primarily focused on discovery of drugs for cancer treatment, is making forays into the asthma market......
(read more)August 1 - News - Comments
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......
(read more)July 29 - News - Comments
After extensive research, number-crunching, sorting, and filtering, the results are in. Here are your three most humongous performers in the world of......
(read more)July 29 - News - Comments
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) has seen a decrease in hedge fund interest of late. According to most shareholders, hedge funds are seen as......
(read more)June 24 - News - Comments
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) was in 11 hedge funds’ portfolio at the end of March. OPTR investors should be aware of a decrease in......
(read more)June 12 - News - Comments
Every week at The Motley Fool we reflect on the top stories in the biotech sector in a wrap-up column. This week was extraordinary, however, as we had......
(read more)June 10 - News - Comments
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shareholders have witnessed a decrease in activity from the world’s largest hedge funds lately. To the......
(read more)April 15 - News - Comments
For the last several years, Merck & Co., Inc. (NYSE:MRK) has been able to ride the success of its leading type 2 diabetes franchise Januvia/Janumet......
(read more)March 26 - News - Comments
Times are changing in the biotech sector. No longer can companies simply sit on their FDA-approved drugs for years at a time, reaping the benefits from......
(read more)February 6 - News - Comments
A quick way to discover potentially undervalued stocks is to look for ones with a current price below the current mean analyst target price. Last year......
(read more)November 16 - Stock Analysis - Comments
